We are live on ! Find out more
MLA

MB, Levis & Associates Portfolio holdings

AUM $271M
1-Year Est. Return 15.56%
This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+15.56%
3 Year Est. Return
+39.99%
5 Year Est. Return
10 Year Est. Return
AUM
$271M
AUM Growth
+$31.7M
Cap. Flow
+$15.6M
Cap. Flow %
5.75%
Top 10 Hldgs %
59.42%
Holding
266
New
32
Increased
93
Reduced
19
Closed
12

Top Sells

Rank Stock Value
1
IBDW icon
iShares iBonds Dec 2031 Term Corporate ETF
IBDW
+$13.7M
2
CAT icon
Caterpillar
CAT
+$47.4K
3
HON icon
Honeywell
HON
+$46.6K
4
ABT icon
Abbott
ABT
+$33.7K
5
FDX icon
FedEx
FDX
+$25.1K

Sector Composition

Rank Sector Weight
1 Miscellaneous 77.73%
2 Technology 5.51%
3 Industrials 5.27%
4 Healthcare 3.16%
5 Financials 2.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RTX icon
26
RTX Corp
RTX
$272B
$1.87M 0.69%
9,834
+107
+1% +$19.6K
TRV icon
27
Travelers Companies
TRV
$78.1B
$1.86M 0.69%
5,633
+13
+0.2% +$3.94K
ADP icon
28
Automatic Data Processing
ADP
$113B
$1.74M 0.64%
7,764
-96
-1% -$20.5K
WMT icon
29
Walmart Inc
WMT
$860B
$1.72M 0.64%
15,214
+37
+0.2% +$4.59K
NSC icon
30
Norfolk Southern
NSC
$73.6B
$1.7M 0.62%
5,388
-37
-0.7% -$11.4K
PG icon
31
Procter & Gamble
PG
$341B
$1.62M 0.6%
11,067
-39
-0.4% -$5.68K
VUG icon
32
Vanguard Morningstar Growth ETF
VUG
$229B
$1.56M 0.58%
18,150
+18
+0.1% +$1.51K
MRK icon
33
Merck
MRK
$376B
$1.51M 0.56%
11,732
-40
-0.3% -$4.68K
ABT icon
34
Abbott
ABT
$188B
$1.37M 0.51%
15,119
-369
-2% -$33.7K
AMGN icon
35
Amgen
AMGN
$240B
$1.06M 0.39%
2,928
-28
-0.9% -$9.59K
XOM icon
36
ExxonMobil
XOM
$667B
$893K 0.33%
6,532
+10
+0.2% +$1.5K
NVDA icon
37
NVIDIA
NVDA
$5.52T
$868K 0.32%
4,339
+1,304
+43% +$268K
PEP icon
38
PepsiCo
PEP
$191B
$856K 0.32%
6,321
+83
+1% +$12.4K
NVS icon
39
Novartis
NVS
$310B
$848K 0.31%
5,410
FDX icon
40
FedEx
FDX
$76.8B
$842K 0.31%
2,690
-69
-3% -$25.1K
NEE icon
41
NextEra Energy
NEE
$175B
$777K 0.29%
8,855
+66
+0.8% +$5.97K
PLD icon
42
Prologis
PLD
$131B
$696K 0.26%
5,140
+40
+0.8% +$5.67K
IBM icon
43
IBM
IBM
$221B
$683K 0.25%
2,427
-12
-0.5% -$3.02K
PNC icon
44
PNC Financial Services
PNC
$97.8B
$675K 0.25%
2,740
+113
+4% +$25.3K
CEF icon
45
Sprott Physical Gold and Silver Trust
CEF
$8.03B
$550K 0.2%
13,667
AMAT icon
46
Applied Materials
AMAT
$346B
$517K 0.19%
715
VCIT icon
47
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.1B
$496K 0.18%
5,999
+4,810
+405% +$398K
CSCO icon
48
Cisco
CSCO
$428B
$490K 0.18%
4,171
-47
-1% -$4.92K
CVX icon
49
Chevron
CVX
$415B
$435K 0.16%
2,626
+858
+49% +$160K
VBR icon
50
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.6B
$428K 0.16%
1,759
+124
+8% +$28.8K

Similar funds

MB, Levis & Associates's Q2 2026 Portfolio in Review

As of Q2 2026, MB, Levis & Associates held 266 positions worth $271M, up 13% from $240M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

MB, Levis & Associates deployed $15.6M of net new capital in Q2 2026, opening 32 new positions and adding to 93 existing holdings. Its largest new stake was iShares iBonds Dec 2036 Term Corporate ETF: 551,113 shares worth $13.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 78% of assets, up from 77% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares iBonds Dec 2031 Term Corporate ETF, an estimated $13.7M trimmed.

  • MB, Levis & Associates's largest Q2 2026 buy was iShares iBonds Dec 2036 Term Corporate ETF: 551,113 shares worth $13.9M.
  • MB, Levis & Associates added most to Vanguard Morningstar Small-Cap ETF in Q2 2026, an estimated $11.9M increase.
  • MB, Levis & Associates's biggest Q2 2026 reduction was iShares iBonds Dec 2031 Term Corporate ETF, cutting an estimated $13.7M.
  • MB, Levis & Associates fully exited Sealed Air in Q2 2026, selling an estimated $11.9K.
  • MB, Levis & Associates's ten largest holdings make up 59% of its $271M portfolio in Q2 2026.
  • MB, Levis & Associates opened 32 new positions and closed 12 in Q2 2026.
  • MB, Levis & Associates's portfolio value rose 13% quarter-over-quarter to $271M.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.